TWI910099B - 用於治療或預防肺囊蟲屬肺炎之三萜類抗真菌劑 - Google Patents

用於治療或預防肺囊蟲屬肺炎之三萜類抗真菌劑

Info

Publication number
TWI910099B
TWI910099B TW109106501A TW109106501A TWI910099B TW I910099 B TWI910099 B TW I910099B TW 109106501 A TW109106501 A TW 109106501A TW 109106501 A TW109106501 A TW 109106501A TW I910099 B TWI910099 B TW I910099B
Authority
TW
Taiwan
Prior art keywords
compound
treatment
pneumocystis
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
TW109106501A
Other languages
English (en)
Chinese (zh)
Other versions
TW202045169A (zh
Inventor
岡札萊茲 大衛 A 安古洛
斯蒂芬 安德魯 巴拉特
Original Assignee
美商塞納西斯公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商塞納西斯公司 filed Critical 美商塞納西斯公司
Publication of TW202045169A publication Critical patent/TW202045169A/zh
Application granted granted Critical
Publication of TWI910099B publication Critical patent/TWI910099B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
TW109106501A 2019-02-27 2020-02-27 用於治療或預防肺囊蟲屬肺炎之三萜類抗真菌劑 TWI910099B (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962811456P 2019-02-27 2019-02-27
US62/811,456 2019-02-27
PCT/US2020/019724 WO2020176527A1 (en) 2019-02-27 2020-02-25 Triterpenoid antifungals for the treatment or prevention of pneumocystis spp. pneumonia
WOPCT/US20/19724 2020-02-25

Publications (2)

Publication Number Publication Date
TW202045169A TW202045169A (zh) 2020-12-16
TWI910099B true TWI910099B (zh) 2026-01-01

Family

ID=70005768

Family Applications (1)

Application Number Title Priority Date Filing Date
TW109106501A TWI910099B (zh) 2019-02-27 2020-02-27 用於治療或預防肺囊蟲屬肺炎之三萜類抗真菌劑

Country Status (15)

Country Link
US (1) US12594266B2 (cg-RX-API-DMAC7.html)
EP (1) EP3930716B1 (cg-RX-API-DMAC7.html)
JP (1) JP7581219B2 (cg-RX-API-DMAC7.html)
KR (1) KR20210133241A (cg-RX-API-DMAC7.html)
CN (1) CN113631165A (cg-RX-API-DMAC7.html)
AU (1) AU2020228036B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021016876A2 (cg-RX-API-DMAC7.html)
CA (1) CA3131298A1 (cg-RX-API-DMAC7.html)
EA (1) EA202192344A1 (cg-RX-API-DMAC7.html)
ES (1) ES3055272T3 (cg-RX-API-DMAC7.html)
IL (1) IL285839A (cg-RX-API-DMAC7.html)
MA (1) MA55081A (cg-RX-API-DMAC7.html)
MX (2) MX2021010311A (cg-RX-API-DMAC7.html)
TW (1) TWI910099B (cg-RX-API-DMAC7.html)
WO (1) WO2020176527A1 (cg-RX-API-DMAC7.html)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166135A (en) * 1988-09-12 1992-11-24 Merck & Company, Inc. Method for the control of pneumocystis carinii

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK173802B1 (da) * 1988-09-12 2001-11-05 Merck & Co Inc Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner
US5756472A (en) 1996-01-31 1998-05-26 Merck & Co., Inc. Antifungal agent obtained from hormonema
ES2402659T3 (es) 2006-04-03 2013-05-07 Merck Sharp & Dohme Corp. Derivados de enfumafungina como agentes antifúngicos
WO2010019204A1 (en) 2008-08-12 2010-02-18 Merck Sharp & Dohme Corp. Antifungal agents
CN108883152A (zh) * 2016-01-08 2018-11-23 奇达拉治疗公司 防止和治疗肺孢子虫感染的方法
JP7263313B2 (ja) * 2017-04-10 2023-04-24 サイネクシス,インコーポレーテッド 併用される抗真菌剤
PL3661503T3 (pl) 2017-08-04 2023-01-09 Scynexis, Inc. Środki przeciwgrzybicze o zwiększonej aktywności przy kwasowym odczynie ph

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166135A (en) * 1988-09-12 1992-11-24 Merck & Company, Inc. Method for the control of pneumocystis carinii

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
網路文獻 Unkown, "SCYNEXIS Data Presentations at ECCMID 2018 Show SCY-078 Potent and Synergistic Antifungal Activity Against Aspergillus and Pneumocystis" SCYNEXIS, April 23, 2018, P.1-3 *

Also Published As

Publication number Publication date
KR20210133241A (ko) 2021-11-05
JP7581219B2 (ja) 2024-11-12
US12594266B2 (en) 2026-04-07
EP3930716A1 (en) 2022-01-05
JP2022523212A (ja) 2022-04-21
MA55081A (fr) 2022-01-05
WO2020176527A1 (en) 2020-09-03
IL285839A (en) 2021-10-31
BR112021016876A2 (pt) 2021-11-03
MX2021010311A (es) 2022-01-04
AU2020228036B2 (en) 2025-08-07
AU2020228036A1 (en) 2021-09-23
ES3055272T3 (en) 2026-02-10
MX2025004197A (es) 2025-09-02
US20230149376A1 (en) 2023-05-18
CA3131298A1 (en) 2020-09-03
TW202045169A (zh) 2020-12-16
EA202192344A1 (ru) 2021-11-15
CN113631165A (zh) 2021-11-09
EP3930716B1 (en) 2025-09-10

Similar Documents

Publication Publication Date Title
US20230364067A1 (en) Antifungal agents with enhanced activity in acidic ph
US20250248983A1 (en) Triterpenoid antifungals for the treatment of fungal osteo-articular infections
JP7581219B2 (ja) ニューモシスチス属種(Pneumocystis spp.)肺炎を治療又は予防するためのトリテルペノイド系抗真菌薬
HK40066679A (en) Triterpenoid antifungals for the treatment of pneumocystis spp. pneumonia
HK40066679B (en) Triterpenoid antifungals for the treatment of pneumocystis spp. pneumonia
HK40091926A (en) Antifungal agents with enhanced activity in acidic ph
HK40062347A (en) Triterpenoid antifungals for the treatment or prevention of pneumocystis spp. pneumonia
HK40109129A (en) Antifungal agents with enhanced activity in acidic ph
HK40030410A (en) Antifungal agents with enhanced activity in acidic ph
HK40030410B (en) Antifungal agents with enhanced activity in acidic ph
EA047126B1 (ru) Противогрибковое средство для лечения или профилактики инфекции вульвовагинального кандидоза